secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2026-06-11T20:05:08+00:00
Accession:  0001193125-26-267485
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics stockholders elect director, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Simeon George, M.D., elected Class II director; 29,205,208 votes for, 7,608,724 withheld, 13,264,883 broker non-votes.
- Ernst & Young ratified as independent auditor for FY 2026; 50,077,708 votes for, 201 against, 906 abstentions.
- Record date April 14, 2026; 62,441,429 shares outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000119312526267485/0001193125-26-267485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000119312526267485/dsgn-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-267485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer